(December 17, 2013) -- The FTC gave the final green light – by a 4-0 vote announced on December 11 – to Actavis Inc.’s acquisition of Warner Chilcott plc after Actavis agreed to sell the rights to three oral contraceptives and an osteoporosis treatment. It will sell these drugs to New Jersey-based Amneal Pharmaceuticals L.L.C....